Group C:Chemotherapy

2 trials

Sponsors

Drum Tower Hospital, Institute of Hematology of Union Hospital

Conditions

Actue leukemiagastric/gastroesophageal junction adenocarcinoma

Phase 2

Relapse leukemia treatment following allogeneic HSCT by CIK

Active, not recruitingChiCTR-TNRC-11001348

Institute of Hematology of Union HospitalActue leukemia

Start: 2011-06-01Updated: 2017-04-18

The efficacy and safety of Tislelizumab combined with Ociperlimab and chemotherapy in the perioperative treatment of resectable esophageal squamous cell carcinoma: a single arm phase II study

RecruitingChiCTR2400092029

Drum Tower Hospitalgastric/gastroesophageal junction adenocarcinoma

Start: 2023-03-15Updated: 2024-11-11